This Biotech Stock Soared 1,400%. Investors Are Optimistic About Its Rare-Disease Drug.
Spruce Biosciences(US:SPRB) Barrons·2025-10-07 13:44公司事件 - 公司股价创下有史以来最佳单日表现 [1] - 美国FDA授予其罕见病药物突破性疗法认定 [1]
Spruce Biosciences(US:SPRB) Barrons·2025-10-07 13:44Spruce Biosciences(US:SPRB) Barrons·2025-10-07 13:44